Twice daily low frequency rTMS for treatment-resistant auditory hallucinations

Galvão, Filipe; Mondino, Marine

doi:10.1016/j.ijchp.2022.100344

Cited by 3 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This approach involves the daily application of low frequency (1 Hz) stimulation to the left temporoparietal cortex (TP3 EEG point) with the coil orientation as originally described by Hoffman et al (Brunelin et al, 2023;Hoffman et al, 2003;Slotema et al, 2014) Negative symptoms of schizophrenia High-frequency forms of rTMS applied to the left DLPFC A number of studies, supported by meta-analysis (Lorentzen et al, 2022;Tseng et al, 2022), have indicated that excitatory/highfrequency forms of rTMS applied to the left DLPFC can have short-term therapeutic benefits for negative symptoms although studies have not yet tested treatment regimens capable of producing longer term/persistent benefits (Garg et al, 2016;Tseng et al, 2022).…”

Section: Low Frequency Stimulus To Left Auditory Cortexmentioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation

Hussain,

Chamoli,

Fitzgerald

et al. 2024

Aust N Z J Psychiatry

View full text Add to dashboard Cite

Objectives: To provide guidance for the optimal administration of repetitive transcranial magnetic stimulation, based on scientific evidence and supplemented by expert clinical consensus. Methods: Articles and information were sourced from existing guidelines and published literature. The findings were then formulated into consensus-based recommendations and guidance by the authors. The guidelines were subjected to rigorous successive consultation within the RANZCP, involving the Section of ECT and Neurostimulation (SEN) Committee, its broader membership and expert committees. Results: The RANZCP professional practice guidelines (PPG) for the administration of rTMS provide up-to-date advice regarding the use of rTMS in clinical practice. The guidelines are intended for use by psychiatrists and non-psychiatrists engaged in the administration of rTMS to facilitate best practice to optimise outcomes for patients. The guidelines strive to find the appropriate balance between promoting best evidence-based practice and acknowledging that evidence for rTMS use is a continually evolving. Conclusion: The guidelines provide up-to-date advice for psychiatrists and non-psychiatrists to promote optimal standards of rTMS practice.

show abstract

Section: Low Frequency Stimulus To Left Auditory Cortexmentioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation

Hussain,

Chamoli,

Fitzgerald

et al. 2024

Aust N Z J Psychiatry

View full text Add to dashboard Cite

show abstract

A narrative review of non-invasive brain stimulation techniques in neuropsychiatric disorders: current applications and future directions

Aderinto,

Olatunji,

Muili

et al. 2024

Egypt J Neurol Psychiatry Neurosurg

View full text Add to dashboard Cite

Background Neuropsychiatric disorders significantly burden individuals and society, necessitating the exploration of innovative treatment approaches. Non-invasive brain stimulation techniques have emerged as promising interventions for these disorders, offering potential therapeutic benefits with minimal side effects. This narrative review provides a comprehensive overview of non-invasive brain stimulation techniques' current applications and future directions in managing neuropsychiatric disorders. Methods A thorough search of relevant literature was conducted to identify studies investigating non-invasive brain stimulation techniques in neuropsychiatric disorders. The selected studies were critically reviewed, and their findings were synthesised to provide a comprehensive overview of the current state of knowledge in the field. Results The review highlights the current applications of non-invasive brain stimulation techniques in neuropsychiatric disorders, including major depressive disorder, Parkinson's disease, schizophrenia, insomnia, and cognitive impairments. It presents evidence supporting the efficacy of these techniques in modulating brain activity, alleviating symptoms, and enhancing cognitive functions. Furthermore, the review addresses challenges such as interindividual variability, optimal target site selection, and standardisation of protocols. It also discusses potential future directions, including exploring novel target sites, personalised stimulation protocols, integrating with other treatment modalities, and identifying biomarkers for treatment response. Conclusion Non-invasive brain stimulation techniques offer promising avenues for managing neuropsychiatric disorders. Further research is necessary to optimise stimulation protocols, establish standardised guidelines, and identify biomarkers for treatment response. The findings underscore the potential of non-invasive brain stimulation techniques as valuable additions to the armamentarium of neuropsychiatric treatments.

show abstract

Opţiuni terapeutice în schizofrenia ultrarezistentă. Intervenţii nonfarmacologice (II)

Vasiliu

2023

Psihiatru.ro

View full text Add to dashboard Cite

Clozapine-resistant or ultra-resistant schizophrenia represents a challenge for clinicians, given the lack of recommendations in all the major treatment guidelines regarding the next steps once clozapine has failed or cannot be tolerated. The first part of this narrative review investigated the pharmacological arsenal available to the clinician to deal with cases of clozapine-resistant schizophrenia. In the present section of the analysis, the results of research that explored the efficacy and tolerability of nonpharmacological methods for this type of schizophrenia will be presented. Ongoing or upcoming clinical trials in patients with ultra-resistant schizophrenia will also be reviewed. Searching electronic databases and clinical trial archives identified seven reports on the effects of psychotherapy and 15 reports on neuromodulation techniques that aimed at ameliorating psychotic symptoms and functionality in clozapine-resistant schizophrenia. A number of six ongoing clinical trials targeting this type of schizophrenia are also presented. In conclusion, based on the data analyzed, cognitive-behavioral therapy for psychosis, cognitive-behavioral therapy, and occupational therapy benefit from moderate-quality data to support their efficacy as add-ons to clozapine in these patients. Except for electroconvulsive therapy, the evidence for other neuromodulation techniques is, at least for now, insufficient to recommend them in ultra-resistant cases. It is necessary to carry out good quality and long-term clinical studies in order to confirm the usefulness of these adjuvant treatments.

show abstract

Twice daily low frequency rTMS for treatment-resistant auditory hallucinations

Cited by 3 publications

References 29 publications

Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation

Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation

A narrative review of non-invasive brain stimulation techniques in neuropsychiatric disorders: current applications and future directions

Opţiuni terapeutice în schizofrenia ultrarezistentă. Intervenţii nonfarmacologice (II)

Contact Info

Product

Resources

About